Header Logo

Connection

Beth Resman-Targoff to Randomized Controlled Trials as Topic

Back to Details
This is a "connection" page, showing publications Beth Resman-Targoff has written about Randomized Controlled Trials as Topic.
Beth Resman-Targoff
Connection Strength
0.062
Randomized Controlled Trials as Topic
  1. Celecoxib versus a non-selective NSAID plus proton-pump inhibitor: what are the considerations?. J Pain Palliat Care Pharmacother. 2006; 20(4):11-32.
    View in: PubMed
    Score: 0.056
  2. Use of cyclosporine in rheumatoid arthritis. Ann Pharmacother. 1993 Jan; 27(1):44-6.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.